A Chart Review Study of Adults With Advanced NSCLC

NCT05207423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2023-02-28

No results posted yet for this study

Summary

The main aim is to see how treatment patterns and drugs might improve care for adults with advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon-20 driven mutations. Past medical records will be reviewed. No clinic visits or procedures will be required.

Conditions

  • Non-small Cell Lung Cancer (NSCLC)

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-03
Primary Completion
2023-02-13
Completion
2023-02-13

Countries

  • Canada
  • France
  • Hong Kong

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05207423 on ClinicalTrials.gov